|
Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - AstraZeneca |
Travel, Accommodations, Expenses - AstraZeneca |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Ipsen; Novartis |
|
|
Consulting or Advisory Role - Abbvie; Gilead Sciences; Merck |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Ipsen; Merck Serono; Novartis; Roche; SERVIER; Shire |
Research Funding - Medac; Novartis |